A drug administered to a patient for treatment, listed in SEER*Rx as a chemotherapeutic, hormonal or immunotherapy agent should be coded under chemotherapy [#1390], hormone therapy [#1400] or immunotherapy [#1410] regardless of the primary site(s) listed in SEER*Rx for that agent. Do not code under the data item, Other Therapy [NAACCR #1420]. Refer to the 2026 SEER manual for more information.

Name Primary Site
Opdivo + cisplatin + gemcitabine Bladder
CCNU-OP Brain
CEF Breast
THP Breast
CAFP Breast
CFM Breast
CAF Breast
TCHP Breast
AC Breast
Phesgo Breast
CAC Breast, Ovary
CAPIRI Colorectal, Esophagus, Stomach
BOLD Colorectal, skin
SMILE Extranodal natural killer/T-cell lymphoma, nasal type (ENKL)
FLOT Gastric-esophageal, Gastric
CFL Head and Neck
C-TPF Head and Neck, stomach
CCAVV Lung
CCVVP Lung
CCVV Lung
COMB Lung, Head and Neck, Melanoma
BEP Testicle
PEBA
PET
FIMe
L-CF
TPCH
Larson Regimen (245)
TOAP
LMF
CVEB
VMPT
CVB
TEE
CVI
PFM
VB
CytaBOM
LVVP
TIC
M2
Cyta BOM
LAMPP
Temozolomide + CRA
ABCD
MABOP
MFP
MACC
ABDIC
ABD
MACE
T-CAP
IE
IDMTX
TBP
ID
Tam Letrozole
Tam Exemestane
TAD
TAC
T-2 protocol
SWOG CMFVP
R-HyperCVAD
TIP
TIT
FOLFOXIRI
FLAG-Ida
MOAP
T-MOP
LOMAC
CNOP
SK
CTX-Plat
TEMP
IROX
JEB
RIDD
IVAC
SCAB
SAM
SIMAL-pilot
SIMAL-bone marrow transplant
LAPOCA
RVD
KGC
KAVE
CTCb
LAM
MCP
MEC
MECY
MCV
ROAP
MeFA
LV5FU2
COPADM
MINE
MINE-ESHAP
mini-BEAM
FUVAC
Glossary